XML 25 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue $ 7,873 $ 0
Cost of revenue 7,078 0
Gross Profit, Total 795 0
Operating expenses:    
Research and development 99,119 71,289
Acquired in-process research and development 425,070 0
Selling, general and administrative 69,233 28,533
Total operating expenses 593,422 99,822
Loss from operations (592,627) (99,822)
Other income (expense):    
Interest income 27,062 24,611
Interest expense (341) 0
Investment advisory fees (976) (949)
Change in fair value of warrants liability (936) 497
Realized loss on marketable securities (12) (139)
Other expense (109) 0
Total other income (expense), net 24,688 24,020
Loss before income taxes (567,939) (75,802)
Provision for income taxes 0 0
Net loss $ (567,939) $ (75,802)
Net loss per share attributable to common stockholders, basic $ (2.11) $ (0.35)
Net loss per share attributable to common stockholders, diluted $ (2.11) $ (0.35)
Weighted average common shares outstanding, basic 268,772 218,880
Weighted average common shares outstanding, diluted 268,772 218,880
Comprehensive loss:    
Net Income (Loss) $ (567,939) $ (75,802)
Other comprehensive loss, net of taxes:    
Currency translation adjustment 537 0
Change in unrealized (loss) gain on available-for-sale securities (145) 5,707
Comprehensive loss $ (567,547) $ (70,095)